The Power of Combining Drugs to Fight Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a type of breast cancer that lacks three specific receptors. This makes it tricky to treat. However, a recent study has shown some promising results. This study looked into how well a mix of two drugs, docetaxel and cisplatin, work together to fight TNBC. It was a phase II trial, which means it was a small-scale test to see i...